Opko Health has acquired Pharmacos Exakta, a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957.
Subscribe to our email newsletter
Opko has acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of Opko Common Stock.
Phillip Frost, chairman and CEO of Opko, said: “We believe this acquisition will provide Opko with an excellent platform to expand manufacturing and distribution capabilities for a wide range of products while, at the same time, maintaining our original interest in ophthalmology.
“It also furthers our strategy of expanding commercial activities while we continue to develop our important diagnostic and therapeutic products, as well as our flu vaccine.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.